Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Head and Neck Cancer

Free Subscription 10.10.2022 1 Am J Gastroenterol 2 Anticancer Res 1 BMC Cancer 5 Clin Cancer Res 3 Head Neck 1 J Nucl Med 2 J Oral Maxillofac Surg 1 Laryngoscope 3 Oral Oncol 2 Otolaryngol Head Neck Surg 1 Radiol Imaging Cancer 3 Radiother Oncol 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. KONDA V, Souza RF, Dunbar KB, Mills JC, et al
   An Endoscopic and Histologic Study on Healing of Radiofrequency Ablation Wounds in Patients With Barrett's Esophagus.
   Am J Gastroenterol. 2022;117:1583-1592.
   PubMed         Abstract available
   
   

   
   Anticancer Res

2. OKADA T, Matsuki T, Fushimi C, Okamoto I, et al
   Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma.
   Anticancer Res. 2022;42:4907-4912.
   PubMed         Abstract available
   
   
3. SAKAI M, Sohda M, Uchida S, Yamaguchi A, et al
   Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT) for Patients With Potentially Resectable Esophageal Cancer.
   Anticancer Res. 2022;42:4929-4935.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. CUI D, Cui X, Xu X, Zhang W, et al
   Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia.
   BMC Cancer. 2022;22:1027.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

5. CABANILLAS ME, Busaidy NL, Sherman SI
   Redifferentiation Therapy-Returning to Our Roots in a Post-Kinase Inhibitor World.
   Clin Cancer Res. 2022;28:4164-4166.
   PubMed         Abstract available
   
   
6. COLEVAS AD
   HPV DNA as a Biomarker in Oropharyngeal Cancer: A Step in the Right Direction.
   Clin Cancer Res. 2022;28:4171-4172.
   PubMed         Abstract available
   
   
7. DUKE ES, Barone AK, Chatterjee S, Mishra-Kalyani PS, et al
   FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer.
   Clin Cancer Res. 2022 Jun 9. pii: 704846. doi: 10.1158/1078-0432.CCR-22-0873.
   PubMed         Abstract available
   
   
8. WEBER M, Kersting D, Riemann B, Brandenburg T, et al
   Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancer With MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study.
   Clin Cancer Res. 2022 May 20. pii: 699089. doi: 10.1158/1078-0432.CCR-22-0437.
   PubMed         Abstract available
   
   
9. BERGER BM, Hanna GJ, Posner MR, Genden EM, et al
   Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma.
   Clin Cancer Res. 2022;28:4292-4301.
   PubMed         Abstract available
   
   

   
   Head Neck

10. HE Y, Li H, Wang K, Wang J, et al
    Fourteen years old as the best age cutoff to differentiate prepubertal from pubertal papillary thyroid carcinoma.
    Head Neck. 2022 Oct 6. doi: 10.1002/hed.27208.
    PubMed         Abstract available
    
    
11. MAZUL AL, Chidambaram S, Zevallos JP, Massa ST, et al
    Disparities in head and neck cancer incidence and trends by race/ethnicity and sex.
    Head Neck. 2022 Oct 6. doi: 10.1002/hed.27209.
    PubMed         Abstract available
    
    
12. SCHLAFSTEIN AJ, Goyal S, Amini A, Karam SD, et al
    The impact of operability status on outcomes in patients with T4 larynx cancer undergoing larynx preservation.
    Head Neck. 2022 Oct 5. doi: 10.1002/hed.27204.
    PubMed         Abstract available
    
    

    
    J Nucl Med

13. SIGNORE A, Campagna G, Marinaccio J, de Vitis M, et al
    Analysis of short term and stable DNA damage in patients with differentiated thyroid cancer treated with (131)I in hypothyroidism or with rhTSH for remnant ablation.
    J Nucl Med. 2022 Feb 3. pii: jnumed.121.263442. doi: 10.2967/jnumed.121.263442.
    PubMed         Abstract available
    
    

    
    J Oral Maxillofac Surg

14. KUMAR A, Ghai S
    RE: Does Total Parotidectomy Improve Survival Over Partial Parotidectomy in Early Stage Adenoid Cystic Carcinoma of the Parotid Gland?
    J Oral Maxillofac Surg. 2022;80:1577.
    PubMed        
    
    
15. LEE KC, Chuang SK
    Reply: Does Total Parotidectomy Improve Survival Over Partial Parotidectomy in Early Stage Adenoid Cystic Carcinoma of the Parotid Gland?
    J Oral Maxillofac Surg. 2022;80:1577-1578.
    PubMed        
    
    

    
    Laryngoscope

16. WU HY, Shan XF, Cai ZG, Zhang J, et al
    Timing of Oral Feeding in Patients Who have Undergone Free Flap Reconstruction for Oral Cancer.
    Laryngoscope. 2022 Oct 6. doi: 10.1002/lary.30435.
    PubMed         Abstract available
    
    

    
    Oral Oncol

17. LIU W, Ji T, Zhang C, Zhou Q, et al
    Cell-free DNA hypermethylated genes may have a limited role in cancer screening but a potential role in risk assessment of head and neck cancer.
    Oral Oncol. 2022;134:106129.
    PubMed         Abstract available
    
    
18. HENG Y, Yang Z, Lin J, Liu Q, et al
    Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis.
    Oral Oncol. 2022;134:106185.
    PubMed         Abstract available
    
    
19. ZHU GL, Fang XL, Yang KB, Tang LL, et al
    Development and validation of a joint model for dynamic prediction of overall survival in nasopharyngeal carcinoma based on longitudinal post-treatment plasma cell-free Epstein-Barr virus DNA load.
    Oral Oncol. 2022;134:106140.
    PubMed         Abstract available
    
    

    
    Otolaryngol Head Neck Surg

20. WIESER ME, Sagalow ES, Givens A, Curry JM, et al
    Occult Metastases During Salvage Oral Cavity and Oropharyngeal Free Flaps: Oncologic Outcomes.
    Otolaryngol Head Neck Surg. 2022;167:645-649.
    PubMed         Abstract available
    
    
21. COHEN ER, Misztal C, Dable C, Gomez-Fernandez C, et al
    Redefining Perineural Invasion in Head and Neck Cutaneous Squamous Cell Carcinoma.
    Otolaryngol Head Neck Surg. 2022;167:705-715.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

22. BAUMGARTEN DA
    O-RADS: Good Enough for Everyday Practice or a Work in Progress?
    Radiol Imaging Cancer. 2022;4:e220121.
    PubMed        
    
    

    
    Radiother Oncol

23. TOPKAN E, Somay E, Yilmaz B
    In regard to recent published study of Massaccesi et al. titled 'A predictive nomogram for trismus after radiotherapy for head and neck cancer'. (Radiother Oncol. 2022 Jun 2: S0167-8140(22)04137-8. doi: 10.1016/j.radonc.2022.05.031).
    Radiother Oncol. 2022;174:132.
    PubMed        
    
    
24. KOO J, Caudell JJ, Latifi K, Jordan P, et al
    Comparative evaluation of a prototype deep learning algorithm for autosegmentation of normal tissues in head and neck radiotherapy.
    Radiother Oncol. 2022;174:52-58.
    PubMed         Abstract available
    
    
25. NADERI E, Schack LMH, Welsh C, Sim AYL, et al
    Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer.
    Radiother Oncol. 2022 Sep 30. pii: S0167-8140(22)04486.
    PubMed         Abstract available
    
    

    
    Thyroid

26. SASAKI T, Miyauchi A, Fujishima M, Ito Y, et al
    Comparison of postoperative unfavorable events in patients with low-risk papillary thyroid carcinoma: Immediate surgery vs. conversion surgery following active surveillance.
    Thyroid. 2022 Oct 7. doi: 10.1089/thy.2022.0444.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: